ARTHROPLASTY
Bisphosphates to prevent femoral periprosthetic bone resorption after cementless THA
J Orthop Surg Res. 2015 May 13;10(1):6510 randomized controlled trials (RCTs) with a total of 525 patients were included in this meta-analysis to determine the effect of bisphosphonates in preventing femoral periprosthetic bone resorption in patients who underwent primary cementless total hip arthroplasty (THA). The femoral periprosthetic bone stock was divided and assessed in seven regions of interest (ROI.) Pooled results demonstrated a decrease in early femoral periprosthetic bone resorption with administration of bisphosphonates.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
